Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Methionyl aminopeptidase 2 pseudogene (ENSG00000273444) is a DNA sequence in the human genome that closely resembles the gene coding for *methionyl aminopeptidase 2* (METAP2), but is classified as a **pseudogene**[5][2]. Pseudogenes like ENSG00000273444 arise from gene duplication or retrotransposition events, and while they have sequence similarity to functional genes, they lack the ability to produce functional protein products owing to disabling mutations or lack of regulatory elements[2][5]. Pseudogenes can sometimes be transcribed or contribute to cellular regulation (such as acting as a source of non-coding RNAs or influencing gene expression), but their function is usually limited and they are not considered valid drug targets or associated directly with disease mechanisms[2][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methionyl aminopeptidase 2 pseudogene (METAP2P).